Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
Authors
Keywords
-
Journal
BMC Medicine
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-04
DOI
10.1186/s12916-019-1428-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events
- (2019) Sean L. Zheng et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials
- (2019) Samuel Seidu et al. Cardiovascular Diabetology
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- Adverse outcomes of long-term use of proton pump inhibitors
- (2018) Md.Mohaimenul Islam et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Impaired aspirin-mediated platelet function inhibition in resuscitated patients with acute myocardial infarction treated with therapeutic hypothermia: a prospective, observational, non-randomized single-centre study
- (2018) Florian Prüller et al. Annals of Intensive Care
- Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
- (2018) J Michael Gaziano et al. LANCET
- Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly
- (2018) John J. McNeil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials
- (2018) Ahmed N Mahmoud et al. EUROPEAN HEART JOURNAL
- Simvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia
- (2018) Cristina Barale et al. Biomed Research International
- Effects of statin therapy on platelet reactivity after percutaneous coronary revascularization in patients with acute coronary syndrome
- (2017) Anna Toso et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Proton-pump inhibitors: understanding the complications and risks
- (2017) Peter Malfertheiner et al. Nature Reviews Gastroenterology & Hepatology
- Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease
- (2017) Monica Verdoia et al. THROMBOSIS RESEARCH
- Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub‐Analysis From the PREFER in AF ( PRE vention o F Thromboembolic Events– E uropean R egistry in A trial F ibrillation)
- (2017) Giuseppe Patti et al. Journal of the American Heart Association
- Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force
- (2016) Janelle M. Guirguis-Blake et al. ANNALS OF INTERNAL MEDICINE
- Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2016) Kirsten Bibbins-Domingo et al. ANNALS OF INTERNAL MEDICINE
- Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes MellitusClinical Perspective
- (2016) Yoshihiko Saito et al. CIRCULATION
- Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials
- (2016) S. K. Kunutsor et al. DIABETIC MEDICINE
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- The influence of statin therapy on platelet activity markers in hyperlipidemic patients after ischemic stroke
- (2015) Malgorzata Pawelczyk et al. Archives of Medical Science
- Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-inflammatory Drugs, Antiplatelet Agents, or Anticoagulants
- (2015) Ángel Lanas et al. Clinical Gastroenterology and Hepatology
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
- (2015) Caroline S. Fox et al. DIABETES CARE
- Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease
- (2015) Sanne Bøjet Larsen et al. PLoS One
- Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or Older With Atherosclerotic Risk Factors
- (2014) Yasuo Ikeda et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Do statins influence platelet reactivity on acetylsalicylic acid therapy in patients with type 2 diabetes?
- (2013) Marek Postula et al. Cardiology Journal
- Statins as Antithrombotic Drugs
- (2013) Francesco Violi et al. CIRCULATION
- Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation
- (2013) John W. Eikelboom et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antiplatelet Treatment for Prevention of Cerebrovascular Events in Patients With Vascular Diseases
- (2013) Ghazaleh Gouya et al. STROKE
- Effect of Aspirin on Vascular and Nonvascular Outcomes
- (2012) Sreenivasa Rao Kondapally Seshasai ARCHIVES OF INTERNAL MEDICINE
- Immediate Antioxidant and Antiplatelet Effect of Atorvastatin via Inhibition of Nox2
- (2012) Pasquale Pignatelli et al. CIRCULATION
- Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin
- (2012) Jolanta M. Siller-Matula et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Hemorrhagic Complications Associated With Aspirin
- (2012) Jolanta M. Siller-Matula JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: A meta-analysis of randomized trials
- (2011) Jeffrey S. Berger et al. AMERICAN HEART JOURNAL
- Meta-Analysis of Multiple Primary Prevention Trials of Cardiovascular Events Using Aspirin
- (2011) Alfred A. Bartolucci et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease
- (2011) Nina Raju et al. AMERICAN JOURNAL OF MEDICINE
- Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis
- (2011) Angel Lanas et al. Clinical Gastroenterology and Hepatology
- Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis
- (2011) E. P. NAVARESE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
- (2010) J. M. Siller-Matula et al. HEART
- Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial IndexA Randomized Controlled Trial
- (2010) F. Gerald R. Fowkes JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis
- (2010) J. M. SILLER-MATULA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Aspirin for primary prevention of cardiovascular disease in diabetes mellitus
- (2010) Michael Pignone et al. Nature Reviews Endocrinology
- Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases
- (2009) Jolanta M Siller-Matula et al. BRITISH JOURNAL OF PHARMACOLOGY
- Smoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular Disease
- (2009) Jeffrey S. Berger et al. CIRCULATION
- Interaction Between Cigarette Smoking and Clinical Benefit of Clopidogrel
- (2009) Nihar R. Desai et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis
- (2008) Jeffrey S. Berger et al. AMERICAN JOURNAL OF MEDICINE
- Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial
- (2008) Hisao Ogawa JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel
- (2008) Kevin P. Bliden et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started